Allergan plc

Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from...

Allergan’s shares were marginally up before the bell. The company lost nearly a fifth of its value last year. In comparison, the wider S&P 500 healthcare index rose 20 percent. Allergan Plc on Tuesday reported a...

News Hour: Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company’s line-up of...

News Hour: Allergan Plc reported quarterly earnings and revenue that topped Wall Street estimates, as higher demand for Botox and eye treatment Restasis helped offset declines in its older drugs, and the company forecast 2017 revenue...

News Hour: Allergan plc (NYSE: AGN), a leading global pharmaceutical company,  announced that it has received a Positive Opinion from the Swedish Medical Products Agency (MPA) for BELKYRA® (deoxycholic acid). BELKYRA® will be the first prescription...

News Hour: Allergan plc (NYSE: AGN) announced that it intends to release second quarter 2016 financial results on Monday, August 8, 2016, prior to the open of the U.S. financial markets. The Company will host a...

News Hour: Allergan plc (NYSE: AGN) announced  that it has filed with the U.S. Food and Drug Administration (FDA) the de novo application for the Oculeve Intranasal Tear Neurostimulator device. According to theFDA, this process provides...

News Hour: Allergan plc (NYSE: AGN) and Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS),  announced that the U.S. Food and Drug Administration (FDA) has approved a new, expanded label for NAMZARIC®(memantine and donepezil hydrochlorides) extended-release, a once-daily, fixed-dose...

News Hour: Allergan plc (NYSE: AGN), a leading global pharmaceutical company,announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a Positive Opinion for TRUBERZI® (eluxadoline) in the European Union.TRUBERZI® is an oral...